谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Sumatriptan, a serotonin 5HT1B receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double‐blinded placebo‐controlled cross‐over trial

Rajna Golubić, Mouhamad Hussein Ismail,Masa Josipovic,Jane Kennet,Alfonso Galderisi,Mark L. Evans

Diabetes, Obesity and Metabolism（2023）

引用 0|浏览11
暂无评分
关键词
serotonin,glucose effectiveness,insulin secretion,receptor agonist
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要